Ignite Creation Date:
2025-12-24 @ 4:27 PM
Ignite Modification Date:
2026-01-02 @ 12:59 PM
Study NCT ID:
NCT00280566
Status:
COMPLETED
Last Update Posted:
2021-03-25
First Post:
2006-01-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-12
Start Date Type:
None
Primary Completion Date:
2008-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-05
Completion Date Type:
ACTUAL
First Submit Date:
2006-01-19
First Submit QC Date:
None
Study First Post Date:
2006-01-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-05-06
Results First Submit QC Date:
None
Results First Post Date:
2009-12-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-02
Last Update Post Date:
2021-03-25
Last Update Post Date Type:
ACTUAL